The Ellis Martin Report: Interview with International Stem Cell Corporation ’ s Founder/Co-Chairman
TEMR: Welcome to The Ellis Martin Report.  I’m Bob Lange.  We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO.   International Stem Cell Corporation has been one of the most exciting companies trading in the biotech sector with respect to non-embryonic stem cell development.  They have a proprietary process and commercial products that give them a tremendous edge in the marketplace. Ken welcome back to the show. I understand there’s a lot going on at International Stem Cell Corporation.  Can you give us at least a portion...
Source: International Stem Cell Corporation - October 21, 2011 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology stem cell international stem cell corporation cosmeceutical Lifeline Cell Technology Lifeline Skin Care stem cell reagent stem cell skin care Source Type: podcasts

The Ellis Martin Report: Interview with International Stem Cell Corporation’s Founder/Co-Chairman
TEMR: Welcome to The Ellis Martin Report.  I’m Bob Lange.  We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO.   International Stem Cell Corporation has been one of the most exciting companies trading in the biotech sector with respect to non-embryonic stem cell development.  They have a proprietary process and commercial products that give them a tremendous edge in the marketplace. Ken welcome back to the show. I understand there’s a lot going on at International Stem Cell Corporation.  Can you give us at least a portion...
Source: International Stem Cell Corporation - October 21, 2011 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology stem cell international stem cell corporation cosmeceutical Lifeline Cell Technology Lifeline Skin Care stem cell reagent stem cell skin care Source Type: podcasts

The Ellis Martin Report: Interview with International Stem Cell Corporation's Founder/Co-Chairman
TEMR: Welcome to The Ellis Martin Report.  I’m Bob Lange.  We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO.   International Stem Cell Corporation has been one of the most exciting companies trading in the biotech sector with respect to non-embryonic stem cell development.  They have a proprietary process and commercial products that give them a tremendous edge in the marketplace. Ken welcome back to the show. I understand there’s a lot going on at International Stem Cell Corporation.  Can you give us at least a portion...
Source: International Stem Cell Corporation - October 21, 2011 Category: Stem Cells Source Type: podcasts

The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.
Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and Applications The Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where I have the pleasure of interviewing Executive Chairman, Kenneth Aldrich. International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISCO a unique leadership role in the field of regene...
Source: International Stem Cell Corporation - August 8, 2011 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell stem cell bank pluripotent international stem cell corporation parkinsons Source Type: podcasts

The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.
Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and Applications The Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where I have the pleasure of interviewing Executive Chairman, Kenneth Aldrich. International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISCO a unique leadership role in the field of rege...
Source: International Stem Cell Corporation - August 8, 2011 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell stem cell bank pluripotent international stem cell corporation parkinsons Source Type: podcasts

The Difference Between Adult Stem Cells and Embryonic Stem Cells
This is Ken Aldrich.  I am Chairman of International Stem Cell Corporation and thought I’d talk for just a minute, or maybe a couple of minutes, about the different kinds of stem cells.  People are always asking, “What’s the difference between an adult stem cell and an embryonic stem cell?”   Let me try to make this as simple as possible.  Adult stem cells are those that are derived from the human body any time after the first, probably, week or two of development of the fetus in the womb. So, cells that come from cord blood, or cells that come from embryonic tissue as well as cells that come from an adult hum...
Source: International Stem Cell Corporation - April 16, 2009 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology health medicine parthenogenesis stem cell bank pluripotent international stem cell corporation alzheimers parkinsons leukemia vectors Source Type: podcasts